Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry
Authors:
- Craig ErkerCECraig Erker
- Adam LaneALAdam Lane
- Sarah LearySLSarah Leary
- Jane E MinturnJMJane E Minturn
- Ute BartelsUBUte Bartels
- Roger J PackerRPRoger J Packer
- Kathleen DorrisKDKathleen Dorris
- Nicholas G GottardoNGNicholas G Gottardo
- Katherine E WarrenKWKatherine E Warren
- Alberto BroniscerABAlberto Broniscer
- Mark W KieranMKMark W Kieran
- 11 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 24 (1) , 141-152
Abstract
DIPG generally occurs in young school-age children, although can occur in adolescents and young adults. The purpose of this study was to describe clinical, radiological, pathologic, and molecular characteristics in patients ≥10 years of age with DIPG enrolled in the International DIPG Registry (IDIPGR). Patients ≥10 years of age at diagnosis enrolled in the IDIPGR with imaging confirmed DIPG diagnosis were included. The primary outcome was overall survival (OS) categorized as long-term survivors (LTS) (≥24 months) or short-term survivors (STS) (PPH3F3A or HIST1H3B), TP53, ATRX, and ACVR1 mutations/genome alterations, respectively. Two of 18 patients with IDH1 testing were IDH1-mutant and one was a LTS. The presence or absence of H3 alterations did not affect survival. Patients ≥10 years old with DIPG have a median survival of 13 months. LTS present with longer symptom duration and are likely to be older at presentation compared to STS. ATRX mutation rates were higher in this population than the general DIPG population.Keywords
This publication has 24 references indexed in Scilit:
- Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteriaNeuro-Oncology, 2014
- Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy – Results of a United Kingdom phase II trial (CNS 2007 04)European Journal of Cancer, 2013
- Molecular analysis of diffuse intrinsic brainstem gliomas in adultsJournal of Neuro-Oncology, 2013
- Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine gliomaJournal of Neuro-Oncology, 2013
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of GlioblastomaCancer Cell, 2012
- K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomasActa Neuropathologica, 2012
- Diffuse intrinsic pontine glioma: poised for progressFrontiers in Oncology, 2012
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Advances Toward an Understanding of Brainstem GliomasJournal of Clinical Oncology, 2006
- Diffuse brainstem glioma in children: critical review of clinical trialsThe Lancet Oncology, 2006